Sunday 8 November 2026 Export MDCX’s income statement to Excel — free account

Medicus Pharma Ltd

MDCX

Healthcare Drug Manufacturers General

EPS: +51.2%
Free cash flow: −27.7%

Quarter to June 2026, against a year earlier

1.87 0.04 +2.19%

Follow MDCX

Alert me

Market cap: $3.5M
P/E: n/m
Fwd P/E: —
Dividend yield: —
F-score: n/a
ROIC: −2,497.5%
Net debt / EBITDA: 0.3×
Dividend safety: n/a

Overview

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(2,660.03%)	(2,981.87%)	(2,877.17%)	(7,441.07%)
ROA Full definition →		(455.33%)	(602.13%)	(786.20%)	(290.34%)
ROIC Full definition →		0.00%	0.00%	0.00%	(2,497.51%)
Return on Tangible Assets Full definition →		4,077.59%	99,562.95%	(3,870.91%)	(923.27%)
Free Cash Flow per Share Full definition →		(51.96)	(65.89)	(47.06)	(26.63)
Free Cash Flow Full definition →		(19.36)	(22.78)	(27.81)	(29.32)
Other line items
Cash ROIC Full definition →		(246.39%)	(260.53%)	(356.78%)	(93.28%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.54	0.48	0.54	0.52
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(51.96)	(65.89)	(47.06)	(26.63)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026